Key insights
- The author suggests Becton Dickinson ($BDX) as a defensive investment due to its dividend yield, essential medical supplies business, and strong market share. They highlight its attractive valuation relative to peers and historical averages, positioning it as a hedge against a risk-off environment. The company's dominant position in needles and syringes provides a solid economic moat.
Currently trading at a discount compared to its peers. forward p/e trading on the lower end compared to peers. currently testing support. good asymmetric risk trade.
as mentioned. they pay 2.8% dividends. good hedge against risk off regime. recession proof
deep value relative to historical average.
pretty solid moat. they make standard medical equipment that hospitals cant do without. the make 30% of the needles and syringes globally. 80% of needles supplied to hospitals in the US comes from them